Efficacy and Safety Study of Fostamatinib Disodium Tablets to Treat T-Cell Lymphoma

Clinical trial NCT00798096 · COMPLETED

Trial details

NCT number: NCT00798096
Sponsor: Rigel Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

T Cell Lymphoma

Start date: 2009-03-01
Primary completion: 2010-04-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.